Technical Support Division, National Institute of Cardiology, Rio de Janeiro, Rio de Janeiro, Brazil.
Faculty of Medicine, Federal University of Juiz de Fora, Juiz de Fora, Minas Gerais, Brazil.
Value Health Reg Issues. 2024 Jul;42:100980. doi: 10.1016/j.vhri.2024.01.002. Epub 2024 Apr 26.
The study aimed to evaluate the cost-effectiveness of the Pare de Fumar Conosco software compared with the standard of care adopted in Brazil for the treatment of smoking cessation.
In the cohort of smokers with multiple chronic conditions, we developed an decision tree model for the benefit measures of smoking cessation. We adopted the perspectives of the Brazilian Unified Health System and the service provider. Resources and costs were measured by primary and secondary sources and effectiveness by a randomized clinical trial. The incremental cost-effectiveness ratio (ICER) was calculated, followed by deterministic and probabilistic sensitivity analyses and deterministic and probabilistic sensitivity analyses. No willingness to pay threshold was adopted.
The software had a lower cost and greater effectiveness than its comparator. The ICER was dominant in all of the benefits examined (-R$2 585 178.29 to -R$325 001.20). The cost of the standard of care followed by that of the electronic tool affected the ICER of the benefit measures. In all probabilistic analyses, the software was superior to the standard of care (53.6%-82.5%).
The Pare de Fumar Conosco software is a technology that results in cost savings in treating smoking cessation.
本研究旨在评估 Pare de Fumar Conosco 软件与巴西采用的戒烟标准护理相比的成本效益。
在患有多种慢性病的吸烟者队列中,我们为戒烟的效益措施开发了一个决策树模型。我们采用了巴西统一卫生系统和服务提供者的观点。资源和成本通过初级和次级来源进行测量,效果通过随机临床试验进行测量。计算了增量成本效益比(ICER),然后进行了确定性和概率敏感性分析以及确定性和概率敏感性分析。未采用支付意愿阈值。
软件的成本低于其对照药物,且效果更好。在所有检查的效益中,ICER 都具有优势(-R$2585178.29 至-R$325001.20)。标准护理的成本和电子工具的成本都会影响效益措施的 ICER。在所有概率分析中,软件均优于标准护理(53.6%-82.5%)。
Pare de Fumar Conosco 软件是一种在治疗戒烟方面可节省成本的技术。